Yukino Chiba

889 total citations
20 papers, 724 citations indexed

About

Yukino Chiba is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Yukino Chiba has authored 20 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 11 papers in Oncology and 3 papers in Hematology. Recurrent topics in Yukino Chiba's work include Psoriasis: Treatment and Pathogenesis (10 papers), Cytokine Signaling Pathways and Interactions (10 papers) and Immune Cell Function and Interaction (6 papers). Yukino Chiba is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (10 papers), Cytokine Signaling Pathways and Interactions (10 papers) and Immune Cell Function and Interaction (6 papers). Yukino Chiba collaborates with scholars based in Japan, United States and Russia. Yukino Chiba's co-authors include Takayuki Yoshimoto, Izuru Mizoguchi, Mingli Xu, Junichiro Mizuguchi, Noriko Morishima, Hideaki Hasegawa, Masae Okumura, Toshiyuki Owaki, Motomu Shimizu and M. Matsui and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Yukino Chiba

20 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yukino Chiba Japan 13 492 251 107 69 68 20 724
Mingli Xu Japan 13 507 1.0× 259 1.0× 189 1.8× 78 1.1× 57 0.8× 28 860
Gaye Erten Türkiye 9 467 0.9× 155 0.6× 118 1.1× 23 0.3× 63 0.9× 15 737
Jesse L. Gurgel United States 5 429 0.9× 176 0.7× 97 0.9× 87 1.3× 38 0.6× 6 700
Matthew J. Ruddy United States 7 785 1.6× 176 0.7× 197 1.8× 105 1.5× 43 0.6× 7 1.2k
Leona Gabryšová United Kingdom 11 517 1.1× 127 0.5× 117 1.1× 40 0.6× 19 0.3× 12 814
Michael Kammüller Switzerland 20 453 0.9× 73 0.3× 108 1.0× 90 1.3× 88 1.3× 43 772
Yasushi Kobayashi Japan 12 675 1.4× 124 0.5× 195 1.8× 24 0.3× 44 0.6× 13 1.0k
Megan E. Himmel Canada 14 577 1.2× 219 0.9× 156 1.5× 28 0.4× 40 0.6× 19 913
Marie Cherrier France 10 1.1k 2.3× 92 0.4× 198 1.9× 53 0.8× 57 0.8× 14 1.3k
Tomohiro Tamachi Japan 15 749 1.5× 105 0.4× 118 1.1× 108 1.6× 17 0.3× 30 1.1k

Countries citing papers authored by Yukino Chiba

Since Specialization
Citations

This map shows the geographic impact of Yukino Chiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukino Chiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukino Chiba more than expected).

Fields of papers citing papers by Yukino Chiba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukino Chiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukino Chiba. The network helps show where Yukino Chiba may publish in the future.

Co-authorship network of co-authors of Yukino Chiba

This figure shows the co-authorship network connecting the top 25 collaborators of Yukino Chiba. A scholar is included among the top collaborators of Yukino Chiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukino Chiba. Yukino Chiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mizoguchi, Izuru, Hideaki Hasegawa, Yukino Chiba, et al.. (2020). EBV-induced gene 3 augments IL-23Rα protein expression through a chaperone calnexin. Journal of Clinical Investigation. 130(11). 6124–6140. 7 indexed citations
2.
Chiba, Yukino, Izuru Mizoguchi, Hideaki Hasegawa, et al.. (2017). Interleukin-27 Exerts Its Antitumor Effects by Promoting Differentiation of Hematopoietic Stem Cells to M1 Macrophages. Cancer Research. 78(1). 182–194. 26 indexed citations
3.
Mizoguchi, Izuru, Yukino Chiba, Hideaki Hasegawa, et al.. (2017). Prediction of Chemical Respiratory and Contact Sensitizers by OX40L Expression in Dendritic Cells Using a Novel 3D Coculture System. Frontiers in Immunology. 8. 929–929. 23 indexed citations
4.
Chiba, Yukino, Izuru Mizoguchi, Hideaki Hasegawa, et al.. (2017). Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases. Cellular and Molecular Life Sciences. 75(8). 1363–1376. 66 indexed citations
5.
Mizoguchi, Izuru, Yukino Chiba, Hideaki Hasegawa, et al.. (2017). Protective effects against tumors and infection by interleukin-27 through promotion of expansion and differentiation of hematopoietic stem cells into myeloid progenitors. OncoImmunology. 7(5). e1421892–e1421892. 3 indexed citations
6.
Hasegawa, Hideaki, et al.. (2016). Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family. Frontiers in Immunology. 7. 479–479. 117 indexed citations
7.
Mizoguchi, Izuru, Yukino Chiba, Masayuki Hisada, et al.. (2016). Promotion of Expansion and Differentiation of Hematopoietic Stem Cells by Interleukin-27 into Myeloid Progenitors to Control Infection in Emergency Myelopoiesis. PLoS Pathogens. 12(3). e1005507–e1005507. 55 indexed citations
8.
Mizoguchi, Izuru, et al.. (2015). Therapeutic potential of interleukin-27 against cancers in preclinical mouse models. OncoImmunology. 4(10). e1042200–e1042200. 4 indexed citations
9.
Yoshimoto, Takayuki, et al.. (2015). Potential clinical application of interleukin‐27 as an antitumor agent. Cancer Science. 106(9). 1103–1110. 42 indexed citations
10.
Yoshimoto, Takayuki, Izuru Mizoguchi, Seiichiro Katagiri, et al.. (2014). Immunosurveillance markers may predict patients who can discontinue imatinib therapy without relapse. OncoImmunology. 3(5). e28861–e28861. 10 indexed citations
11.
Chiba, Yukino, Izuru Mizoguchi, Hiroshi Nagai, et al.. (2013). IL-27 Enhances the Expression of TRAIL and TLR3 in Human Melanomas and Inhibits Their Tumor Growth in Cooperation with a TLR3 Agonist Poly(I:C) Partly in a TRAIL-Dependent Manner. PLoS ONE. 8(10). e76159–e76159. 28 indexed citations
12.
Shimizu, Motomu, Kiyoshi Ogura, Izuru Mizoguchi, et al.. (2012). IL-27 promotes nitric oxide production induced by LPS through STAT1, NF-κB and MAPKs. Immunobiology. 218(4). 628–634. 27 indexed citations
13.
Yoshimoto, Takayuki, Mingli Xu, Yukino Chiba, et al.. (2012). Regulation of inflammatory immune responses leading to the development of bone destructive autoimmune disease rheumatoid arthritis by IL-27. Arthritis Research & Therapy. 14(S1). 3 indexed citations
14.
Xu, Mingli, Noriko Morishima, Izuru Mizoguchi, et al.. (2011). Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production (114.13). The Journal of Immunology. 186(1_Supplement). 114.13–114.13. 3 indexed citations
15.
Xu, Mingli, Noriko Morishima, Izuru Mizoguchi, et al.. (2011). Regulation of the development of acute hepatitis by IL‐23 through IL‐22 and IL‐17 production. European Journal of Immunology. 41(10). 2828–2839. 31 indexed citations
16.
Kamiya, Sadahiro, Masae Okumura, Yukino Chiba, et al.. (2011). IL-27 suppresses RANKL expression in CD4+ T cells in part through STAT3. Immunology Letters. 138(1). 47–53. 42 indexed citations
17.
Xu, Mingli, Noriko Morishima, Izuru Mizoguchi, et al.. (2011). Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production. European Journal of Immunology. n/a–n/a. 3 indexed citations
18.
Xu, Mingli, Izuru Mizoguchi, Noriko Morishima, et al.. (2010). Regulation of Antitumor Immune Responses by the IL‐12 Family Cytokines, IL‐12, IL‐23, and IL‐27. Journal of Immunology Research. 2010(1). 161 indexed citations
19.
Morishima, Noriko, Izuru Mizoguchi, Masae Okumura, et al.. (2010). A Pivotal Role for Interleukin-27 in CD8+T Cell Functions and Generation of Cytotoxic T Lymphocytes. SHILAP Revista de lepidopterología. 2010. 1–10. 51 indexed citations
20.
Yoshimoto, Takayuki, Noriko Morishima, Masae Okumura, et al.. (2009). Interleukins and Cancer Immunotherapy. Immunotherapy. 1(5). 825–844. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingli Xu Breakdown of academic impact, for papers by Gaye Erten Breakdown of academic impact, for papers by Jesse L. Gurgel Breakdown of academic impact, for papers by Matthew J. Ruddy Breakdown of academic impact, for papers by Leona Gabryšová Breakdown of academic impact, for papers by Michael Kammüller Breakdown of academic impact, for papers by Yasushi Kobayashi Breakdown of academic impact, for papers by Megan E. Himmel Breakdown of academic impact, for papers by Marie Cherrier Breakdown of academic impact, for papers by Tomohiro Tamachi
Rankless by CCL
2026